United Therapeutics Corporation (UTHR) Gross margin 2016–2025
United Therapeutics Corporation (UTHR) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.9%FY2025 · since FY2016: 95.5% → 87.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.9% | -1.3 pp |
| FY2024 | 89.2% | +0.3 pp |
| FY2023 | 88.9% | -3.2 pp |
| FY2022 | 92.2% | -0.6 pp |
| FY2021 | 92.7% | +0.0 pp |
| FY2020 | 92.7% | +0.8 pp |
| FY2019 | 91.9% | +4.1 pp |
| FY2018 | 87.8% | -6.1 pp |
| FY2017 | 93.9% | -1.6 pp |
| FY2016 | 95.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice